Bayer’s third-quarter sales came in a bit higher than anticipated, but the company is girding its loins for a challenging period ahead.
More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more
Welcome back to another edition of Endpoints Weekly. Two of the year’s major oncology conferences are coming up soon: AACR starting April 17, and ASCO



